Two Sigma Securities, LLC Gilead Sciences, Inc. Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

A detailed history of Two Sigma Securities, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 45,900 shares of GILD stock, worth $4.12 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

45,900

Previous 51,400 10.7%

Holding current value

$4.12 Million

Previous $3.53 Million 9.1%

% of portfolio

0.07%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $1.9 Million - $2.32 Million	26,567 New	26,567 $1.95 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.83 Million - $3.09 Million	38,267 New	38,267 $2.87 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $1.18 Million - $1.69 Million	-18,881 Reduced 81.51%	4,283 $367,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $965,798 - $1.1 Million	16,221 Added 233.63%	23,164 $1.43 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $322,193 - $362,885	-5,582 Reduced 44.57%	6,943 $429,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $581,512 - $635,384	9,162 Added 272.44%	12,525 $862,000
Q2 2020 Sep 10, 2020	SELL	$72.34 - $84.0 $2.48 Million - $2.88 Million	-34,300 Reduced 91.07%	3,363 $259,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $1.91 Million - $2.22 Million	26,442 Added 235.65%	37,663 $2.9 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $85,677 - $109,740	1,368 Added 13.88%	11,221 $839,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $607,141 - $667,836	9,853 New	9,853 $640,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $534,710 - $590,226	-8,554 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $297,223 - $333,301	-4,804 Reduced 35.96%	8,554 $578,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $160,639 - $179,958	2,569 Added 23.81%	13,358 $868,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $1.14 Million - $1.48 Million	-18,786 Reduced 63.52%	10,789 $675,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1,782 - $1,973	-25 Reduced 0.08%	29,575 $2.28 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $1.45 Million - $1.69 Million	-22,340 Reduced 43.01%	29,600 $2.1 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $458,673 - $559,173	6,297 Added 13.8%	51,940 $3.92 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $3.25 Million - $3.81 Million	45,643	45,643 $3.27 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account

Two Sigma Securities, LLC Gilead Sciences, Inc. Transaction History